Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 12 results:
Author Title Type [ Year] Filters: Keyword is Glucagon-Like Peptide 1 [Clear All Filters]
Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis..
Hormones (Athens). 22(4), 655-664.
(2023). Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease..
Curr Pharm Des. 29(41), 3263-3265.
(2023). Socioeconomic aspects of incretin-based therapy..
Diabetologia. 66(10), 1859-1868.
(2023). Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis..
Diabetologia. 65(8), 1251-1261.
(2022).
(2019).
(2017).
Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?.
Curr Vasc Pharmacol. 14(6), 494-497.
(2016). Emerging and future therapies for nonalcoholic steatohepatitis in adults..
Expert Opin Pharmacother. 17(14), 1937-46.
(2016). Study of postprandial lipaemia in type 2 diabetes mellitus: exenatide versus liraglutide..
J Diabetes Res. 2014, 304032.
(2014).
(2012).
Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control..
Diabetes Obes Metab. 13(4), 302-12.
(2011). The incretin effect and secretion in obese and lean women with polycystic ovary syndrome: a pilot study..
J Womens Health (Larchmt). 20(6), 971-6.
(2011).